Etiological diagnosis and drug resistance analysis of non-classic microbial infections

doi:10.3969/j.issn.1673-8640.2018.12.001

Abstract

Abstract:

：With the extensive use of invasive diagnostic and therapeutic methods as well as immunosuppressive agents,hormones and antimicrobial agents,non-classic microbial infections are becoming more and more common. The issue,the etiological diagnosis and drug resistance analysis in vitro of non-classic microbial infections,includes on 3 articles,1 review and 1 case report. They expound the etiological diagnosis and drug resistance analysis of non-classic microorganisms,such as nontuberculous Mycobacterium,Mycoplasma and Chlamydia trachomatis. They provide a reference for the diagnosis and treatment of non-classic microbial infections.

Key words: Non-classic microorganism, Nontuberculous Mycobacterium, Mycoplasma, Chlamydia trachomatis, Etiological diagnosis, Drug resistance analysis

CLC Number:

R446.1

ZHAO Hu, ZHANG Jinghao, ZHANG Yanmei. Etiological diagnosis and drug resistance analysis of non-classic microbial infections[J]. Laboratory Medicine, 2018, 33(12): 1063-1066.

References 21

1	SHIH D C,CASSIDY P M,PERKINS K M,et al.Extrapulmonary nontuberculous mycobacterial disease surveillance-Oregon,2014-2016[J]. MMWR Morb Mortal Wkly Rep,2018,67(31):854-857.
2	岳晓丽,龚向东,滕菲,等. 2008-2015年中国性病监测点生殖道沙眼衣原体感染流行特征分析[J]. 中华皮肤科杂志,2016,49(5):308-313.
3	中华医学会结核病学分会,《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识[J]. 中华结核和呼吸杂志,2012,35(8):572-580.
4	BRYANT J M,GROGONO D M,RODRIGUEZ-RINCON D,et al.Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium[J]. Science,2016,354(6313):751-757.
5	周庭银,章强强. 临床微生物学诊断与图解[M]. 4版. 上海:上海科学技术出版社,2017:282-285,580-581.
6	中华医学会结核病学分会,非结核分枝杆菌病实验室诊断专家共识编写组. 非结核分枝杆菌病实验室诊断专家共识[J]. 中华结核和呼吸杂志,2016,39(6):438-443.
7	全国第五次结核病流行病学抽样调查技术指导组,全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志,2012,34(8):485-508.
8	SHIAU M Y,LEE M S,HUANG T L,et al.Mycobacterial prevalence and antibiotic resistance frequency trends in Taiwan of mycobacterial clinical isolates from 2002 to 2014[J]. Medicine(Baltimore),2016,95(12):e2942.
9	Clinical and Laboratory Standards Institute.Susceptibility test of Mycobacteria,Nocardiae,and other aerobic actinomycetes[S]. M24-A2,CLSI,2011.
10	胡飞枢. 中国大陆地区非结核分枝杆菌对29种抗菌药物的体外耐药情况研究——meta分析以及脓肿分枝杆菌的胞内药敏方法研究[D]. 杭州:浙江大学,2016.
11	李青曌,史文元,陈虹亮. 肺炎支原体的实验室检测技术研究进展[J]. 中国人兽共患病学报,2017,33(9):841-844.
12	李维娜,朱文兵,刘刚. 生殖支原体感染的研究进展[J]. 中华检验医学杂志,2018,41(4):328-332.
13	WILDENBEEST J G,SAID I,JAEGER B,et al.Neonate with Mycoplasma hominis meningoencephalitis given moxifloxacin[J]. Lancet Infect Dis,2016,16(11):e261-e266.
14	张岱,刘朝晖. 生殖道支原体感染诊治专家共识[J]. 中国性科学,2016,25(3):80-82.
15	吴文湘,刘朝晖. 重视女性生殖道淋菌沙眼衣原体及支原体感染的临床诊治[J]. 中华检验医学杂志,2018,41(4):263-266.
16	Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing for human mycoplasmas[S]. M43-A,CLSI,2011.
17	张有江,张军民,罗燕萍,等. 400例泌尿生殖道支原体、衣原体检测及药敏结果分析[J]. 中华医院感染学杂志,2003,13(7):689-690.
18	张丽丽,姚蓓,康辉跃,等. 3 864份泌尿生殖道标本支原体检测及药敏分析[J]. 国际检验医学杂志,2016,37(15):2165-2166.
19	TORRONE E,PAPP J,WEINSTOCK H,et al.Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years-United States,2007-2012[J]. MMWR Morb Mortal Wkly Rep,2014,63(38):834-838.
20	刘朝晖,薛凤霞. 女性生殖道沙眼衣原体感染诊治共识[J]. 中国实用妇科与产科杂志,2015,31(9):791-793.
21	刘志超,刘原君,冯斌,等. 四种检测泌尿生殖道沙眼衣原体方法的比较与评价[J]. 中国皮肤性病学杂志,2011,25(8):641-643.

[1]	CHEN Naihan, SA Yalian. Overview of detection methods for Mycoplasma in cell preparations [J]. Laboratory Medicine, 2022, 37(7): 684-687.
[2]	DNA XU Mingyong, ZHU Huaqiang, WU Yonghua, ZHUANG Lidong. Preparation and evaluation of the quality control materials of Chlamydia trachomatis [J]. Laboratory Medicine, 2021, 36(1): 107-110.
[3]	XUAN Binbin, TAN Meiyu, SUN Hanxiao, SHENG Huiming. Mixed infection status of human papillomavirus,Ureaplasma urealyticum,Chlamydia trachomatis and Neisseria gonorrhoeae in Changning district of Shanghai [J]. Laboratory Medicine, 2020, 35(9): 859-863.
[4]	GUO Shuli, LUO Xiandao, JIA Haiying, YANG Liwei, HUANG Guohong, WANG Changmin. Analysis of co-infection of GBS and Mycoplasma in perinatal women [J]. Laboratory Medicine, 2020, 35(5): 451-454.
[5]	ZHAO Jinyun, JIN Faxiang, XU Wenfang, XU Peng, TONG Dan. Status analysis of lung infection caused by nontuberculous Mycobacterium in Shaoxing [J]. Laboratory Medicine, 2020, 35(2): 125-128.
[6]	CAO Hui, XIA Wanbao, DING Xiali, LIU Jun, PENG Jinghong. Analysis of the characteristics of sexually transmitted disease infection in Songjiang District of Shanghai [J]. Laboratory Medicine, 2019, 34(9): 804-807.
[7]	LI Dan, DU Debing, WU Wenyan, WANG Decheng. Gene chip technology in the identification and drug resistance of Mycobacterium [J]. Laboratory Medicine, 2019, 34(2): 165-168.
[8]	GU Weiming. Research progress of immunochromatography assay and its clinical application in Chlamydia trachomatis infection [J]. Laboratory Medicine, 2018, 33(12): 1067-1070.
[9]	CAI Jinfeng, ZHANG Guihong, ZHENG Jianghua. Isolation and drug resistance of Mycobacterium from AIDS patients in Shanghai from 2012 to 2016 [J]. Laboratory Medicine, 2018, 33(12): 1071-1075.
[10]	CHEN Kai, HAN Yan, YIN Yueping, ZHONG Mingying, ZHU Bangyong, SHI Meiqin. Parallel comparison of 7 kinds of domestic Chlamydia trachomatis nucleic acid test reagents [J]. Laboratory Medicine, 2018, 33(12): 1081-1085.
[11]	WANG Xueliang, LIU Fen, JIANG Lingli, BAO Yun, YANG Yixiao, XIAO Yanqun, WANG Hualiang. Rapid determination of Chlamydia trachomatis by loop-mediated isothermal amplification [J]. Laboratory Medicine, 2017, 32(9): 809-812.
[12]	YANG Yang, YANG Zhiqi, ZHOU Yunheng, CHEN Xiangming, TANG Qunli, GU Weiming. Comparison on combined culturing with solid-liquid media and molecular determination for Mycoplasma [J]. Laboratory Medicine, 2017, 32(9): 813-817.